Fonar Corp (FONR)
16.00
+0.23
(+1.46%)
USD |
NASDAQ |
Jun 28, 16:00
15.90
-0.10
(-0.62%)
After-Hours: 20:00
Fonar Accounts Receivable (Quarterly): 26.92M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 26.92M |
December 31, 2023 | 75.05M |
September 30, 2023 | 73.20M |
June 30, 2023 | 25.12M |
March 31, 2023 | 68.50M |
December 31, 2022 | 67.54M |
September 30, 2022 | 66.77M |
June 30, 2022 | 24.44M |
March 31, 2022 | 64.78M |
December 31, 2021 | 63.31M |
September 30, 2021 | 62.60M |
June 30, 2021 | 61.20M |
March 31, 2021 | 59.17M |
December 31, 2020 | 57.61M |
September 30, 2020 | 56.50M |
June 30, 2020 | 54.82M |
March 31, 2020 | 55.36M |
December 31, 2019 | 54.57M |
September 30, 2019 | 53.01M |
June 30, 2019 | 51.68M |
March 31, 2019 | 50.21M |
December 31, 2018 | 47.40M |
September 30, 2018 | 46.01M |
June 30, 2018 | 44.56M |
March 31, 2018 | 42.47M |
Date | Value |
---|---|
December 31, 2017 | 42.19M |
September 30, 2017 | 40.99M |
June 30, 2017 | 39.62M |
March 31, 2017 | 38.68M |
December 31, 2016 | 37.03M |
September 30, 2016 | 35.94M |
June 30, 2016 | 34.20M |
March 31, 2016 | 34.38M |
December 31, 2015 | 32.42M |
September 30, 2015 | 32.12M |
June 30, 2015 | 30.44M |
March 31, 2015 | 31.40M |
December 31, 2014 | 31.14M |
September 30, 2014 | 30.17M |
June 30, 2014 | 28.66M |
March 31, 2014 | 29.51M |
December 31, 2013 | 29.58M |
September 30, 2013 | 28.40M |
June 30, 2013 | 26.42M |
March 31, 2013 | 26.72M |
December 31, 2012 | 11.40M |
September 30, 2012 | 4.91M |
June 30, 2012 | 10.19M |
March 31, 2012 | 6.236M |
December 31, 2011 | 4.823M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
24.44M
Minimum
Jun 2022
75.05M
Maximum
Dec 2023
56.11M
Average
58.39M
Median
Accounts Receivable (Quarterly) Benchmarks
XWELL Inc | 2.90M |
ProPhase Labs Inc | 35.12M |
Applied DNA Sciences Inc | 0.4089M |
Veracyte Inc | 46.66M |
OncoCyte Corp | 0.161M |